Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
1 result
Filters applied: . Clear all
Page 1
Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis.
Respir Med. 2017 Dec;133:12-15. doi: 10.1016/j.rmed.2017.11.007. Epub 2017 Nov 10.
Respir Med. 2017.
PMID: 29173443
Free article.
The mainstay treatment consists of a combination of corticosteroids and antifungals. However, repeated or long-term corticosteroid therapies can lead to serious side effects. The monoclonal anti-IgE antibody, omalizumab, has demonstrated its efficacy in allergic asthma. .. …
The mainstay treatment consists of a combination of corticosteroids and antifungals. However, repeated or long-term corticosteroid th …
Cite
Cite